These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22699096)

  • 1. Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users.
    Roy E; Arruda N; Leclerc P; Haley N; Bruneau J; Boivin JF
    Drug Alcohol Depend; 2012 Nov; 126(1-2):246-50. PubMed ID: 22699096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience.
    Roy E; Boudreau JF; Boivin JF
    Drug Alcohol Depend; 2009 Jun; 102(1-3):158-61. PubMed ID: 19251382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.
    Bruneau J; Roy E; Arruda N; Zang G; Jutras-Aswad D
    Addiction; 2012 Jul; 107(7):1318-27. PubMed ID: 22248184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cessation of injecting drug use among street-based youth.
    Steensma C; Boivin JF; Blais L; Roy E
    J Urban Health; 2005 Dec; 82(4):622-37. PubMed ID: 16195471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
    Fuller CM; Ompad DC; Galea S; Wu Y; Koblin B; Vlahov D
    J Urban Health; 2004 Mar; 81(1):20-4. PubMed ID: 15047780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
    Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
    Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for hepatitis C virus infection among street youths.
    Roy E; Haley N; Leclerc P; Boivin JF; Cédras L; Vincelette J
    CMAJ; 2001 Sep; 165(5):557-60. PubMed ID: 11563207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
    Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
    Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.
    Bravo MJ; Vallejo F; Barrio G; Brugal MT; Molist G; Pulido J; Sordo L; de la Fuente L;
    Int J Drug Policy; 2012 Sep; 23(5):415-9. PubMed ID: 22421554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities.
    Hagan H; Pouget ER; Williams IT; Garfein RL; Strathdee SA; Hudson SM; Latka MH; Ouellet LJ
    J Infect Dis; 2010 Feb; 201(3):378-85. PubMed ID: 20053137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.
    Wand H; Spiegelman D; Law M; Jalaludin B; Kaldor J; Maher L
    Addiction; 2009 Dec; 104(12):2049-56. PubMed ID: 19804463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
    Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
    Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
    Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
    Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
    Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus seroconversion among young injection drug users: relationships and risks.
    Hahn JA; Page-Shafer K; Lum PJ; Bourgois P; Stein E; Evans JL; Busch MP; Tobler LH; Phelps B; Moss AR
    J Infect Dis; 2002 Dec; 186(11):1558-64. PubMed ID: 12447730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation to drug injection among street youth: a gender-based analysis.
    Roy E; Boivin JF; Leclerc P
    Drug Alcohol Depend; 2011 Mar; 114(1):49-54. PubMed ID: 20950965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
    Smyth BP; Barry J; Keenan E
    Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between first injection risk behaviors and hepatitis C seropositivity among injecting drug users.
    Vidal-Trecan GM; Varescon-Pousson I; Gagnière B; Tcherny- Lessenot S; Madariaga E; Boissonnas A
    Ann Med Interne (Paris); 2002 Jun; 153(4):219-25. PubMed ID: 12218887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.